BACKGROUND: The VA Stroke Prevention in Nonrheumatic Atrial Fibrillation study was a prospective, randomized, double-blind study comparing low-dose warfarin with placebo in patients with nonrheumatic atrial fibrillation. The trial showed a 79% reduction in stroke rate in warfarin randomized patients without an increase in bleeding complications. We examined the need for frequent prothrombin time monitoring (international normalized ratios [INR] were not measured directly) in patients receiving warfarin.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/107424849900400102 | DOI Listing |
Publication Analysis
Top Keywords
nonrheumatic atrial
8
atrial fibrillation
8
initiating maintaining
4
patients
4
maintaining patients
4
warfarin
4
patients warfarin
4
warfarin anticoagulation
4
anticoagulation monitoring
4
monitoring background
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!